Research of the domestic market of medicinal products used for diseases of the nasal cavity

Diseases of the nasal cavity have a significant impact on overall health, as the nasal cavity is an important part of the respiratory system and performs significant functions in protecting the body. Well-known pathologies such as rhinitis, sinusitis, nasopharyngitis, and allergic rhinitis are common diseases that most people face throughout their lives. The study of the domestic market of medicinal products used in the treatment of nasal cavity diseases is extremely relevant today. In the context of the global pandemic, various viral or bacterial diseases with a decrease in immunity against the background of the ongoing war in Ukraine, there is a spread of nasal cavity diseases. The aim of the study has been to conduct a market research of the domestic market of medicines used in the treatment of nasal cavity diseases to meet market needs and provide the population with high-quality and affordable medicines for the treatment of nasal cavity diseases. In the course of the study, the systematic and analytical, comparative, and mathematical and statistical methods of analysis were used, using official data from information websites. The results of the analysis of ATC group R01 «Drugs used in diseases of the nasal cavity» showed that the current pharmaceutical market of Ukraine has 195 medicines of this type offered by 10 pharmaceutical companies from Ukraine and 41 companies from 19 countries. An analysis of the range of nasal medicines marketed in Ukraine showed the heterogeneity of this market segment: solid, liquid and soft dosage forms, both original and generic, are available. The study of the competitiveness of manufacturers of this group of medicinal products revealed that the greatest competition is observed among manufacturers of Xylometazoline hydrochloride, Oxymetazoline hydrochloride and Mometasone furoate. The calculation of the segment share and monopolisation ratio of the Ukrainian market showed that JSC Farmak (Ukraine) gained absolute leadership, having the highest monopolisation ratio and the highest share in the segment under study.